[1] |
Ferri M, Ranucci E, Romagnoli P, et al. Antimicrobial resis-tance: A global emerging threat to public health systems. Crit Rev Food Sci Nutr, 2017, 57(13):2857-2876. doi: 10.1080/10408398.2015.1077192.
doi: 10.1080/10408398.2015.1077192
URL
|
[2] |
Singh V, Chibale K. Strategies to Combat Multi-Drug Resis-tance in Tuberculosis. Acc Chem Res, 2021, 54(10):2361-2376. doi: 10.1021/acs.accounts.0c00878.
doi: 10.1021/acs.accounts.0c00878
URL
|
[3] |
World Health Organization. Global tuberculosis report 2020. Geneva: World Health Organization, 2020.
|
[4] |
Zhao Y, Xu S, Wang L, et al. National survey of drug-resis-tant tuberculosis in China. N Engl J Med, 2012, 366(23):2161-2170. doi: 10.1056/NEJMoa1108789.
doi: 10.1056/NEJMoa1108789
URL
|
[5] |
郑惠文, 赵雁林. 中国结核病耐药监测现状与监测体系建设. 中国实用内科杂志, 2015, 35(8):647-650. doi: 10.7504/nk2015070102.
doi: 10.7504/nk2015070102
|
[6] |
马爱静, 赵雁林. 耐药结核病的流行和监测现状. 中国抗生素杂志, 2018, 43(5):502-506. doi: 10.3969/j.issn.1001-8689.2018.05.002.
doi: 10.3969/j.issn.1001-8689.2018.05.002
|
[7] |
国务院办公厅. 国务院办公厅关于印发“十三五”全国结核病防治规划的通知. 国办发〔2017〕16号. 2017-02-06.
|
[8] |
吴智龙, 钟倩红, 郭翠弟. 广东省佛山市肺结核患者耐药情况分析. 中国防痨杂志, 2016, 38(7):597-600. doi: 10.3969/j.issn.1000-6621.2016.07.017.
doi: 10.3969/j.issn.1000-6621.2016.07.017
|
[9] |
Nguyen L. Antibiotic resistance mechanisms in M.tuberculosis: an update. Arch Toxicol, 2016, 90(7):1585-1604. doi: 10.1007/s00204-016-1727-6.
doi: 10.1007/s00204-016-1727-6
pmid: 27161440
|
[10] |
Chien JY, Chen YT, Wu SG, et al. Treatment outcome of patients with isoniazid mono-resistant tuberculosis. Clin Microbiol Infect, 2015, 21(1):59-68. doi: 10.1016/j.cmi.2014.08.008.
doi: 10.1016/j.cmi.2014.08.008
URL
|
[11] |
Sharma SK, Upadhyay V. Epidemiology, diagnosis & treatment of non-tuberculous mycobacterial diseases. Indian J Med Res, 2020, 152(3):185-226. doi: 10.4103/ijmr.IJMR_902_20.
doi: 10.4103/ijmr.IJMR_902_20
URL
|
[12] |
洪创跃, 李金莉, 赵广录, 等. 2013—2017年深圳市非结核分枝杆菌流行状况分析. 中国防痨杂志, 2019, 41(5):529-533. doi: 10.3969/j.issn.1000-6621.2019.05.011.
doi: 10.3969/j.issn.1000-6621.2019.05.011
|
[13] |
王春花, 孙蕊, 王志锐, 等. 2011—2015年天津地区非结核分枝杆菌感染趋势及耐药情况分析. 中国防痨杂志, 2017, 39(11):1250-1253. doi: 10.3969/j.issn.1000-6621.2017.11.020.
doi: 10.3969/j.issn.1000-6621.2017.11.020
|
[14] |
Kontturi A, Soini H, Ollgren J, et al. Increase in Childhood Nontuberculous Mycobacterial Infections After Bacille Calmette-Guérin Coverage Drop: A Nationwide, Population-Based Retrospective Study, Finland, 1995-2016. Clin Infect Dis, 2018, 67(8):1256-1261. doi: 10.1093/cid/ciy241.
doi: 10.1093/cid/ciy241
pmid: 29584893
|
[15] |
Gopalaswamy R, Shanmugam S, Mondal R, et al. Of tuberculosis and non-tuberculous mycobacterial infections-a comparative analysis of epidemiology, diagnosis and treatment. J Biomed Sci, 2020, 27(1):74. doi: 10.1186/s12929-020-00667-6.
doi: 10.1186/s12929-020-00667-6
pmid: 32552732
|
[16] |
Suthar AB, Moonan PK, Alexander HL. Towards national systems for continuous surveillance of antimicrobial resistance: Lessons from tuberculosis. PLoS Med, 2018, 15(9):e1002658. doi: 10.1371/journal.pmed.1002658.
doi: 10.1371/journal.pmed.1002658
URL
|
[17] |
Ruan YZ, Li L, Lin X, et al. Practical Experiences of Delivering Multidrug-Resistant Tuberculosis Comprehensive Supportive Care Services in China. China CDC Weekly, 2021, 3(26):566-568. doi: 10.46234/ccdcw2021.146.
doi: 10.46234/ccdcw2021.146
URL
|
[18] |
杨婷婷, 高谦. 构建基于全基因组数据的结核病耐药及传播监测网络. 中国防痨杂志, 2021, 43(7):645-648. doi: 10.3969/j.issn.1000-6621.2021.07.001.
doi: 10.3969/j.issn.1000-6621.2021.07.001
|
[19] |
张洁, 任怡宣, 潘丽萍, 等. 全基因组测序在结核分枝杆菌研究中的应用. 中国防痨杂志, 2020, 42(7):737-740. doi: 10.3969/j.issn.1000-6621.2020.07.017.
doi: 10.3969/j.issn.1000-6621.2020.07.017
|
[20] |
中国防痨协会. 结核病领域研究进展(2020年度). 中国防痨杂志, 2021, 43(1):6-11. doi: 10.3969/j.issn.1000-6621.2021.01.003.
doi: 10.3969/j.issn.1000-6621.2021.01.003
|